Krystal Biotech, Inc. KRYS announced initial clinical data updates on its two inhaled genetic medicine pipeline candidates, KB407 and KB408, which are being developed in early-stage studies for ...
William Blair analyst Sami Corwin has maintained their bullish stance on KRYS stock, giving a Buy rating yesterday. Pick the best stocks and maximize your portfolio: Discover top-rated stocks from ...